Business Description
Cantel Medical Corp
NAICS : 339112
SIC : 3841
ISIN : US1380981084
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.23 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 1.15 | |||||
Debt-to-EBITDA | 4.4 | |||||
Interest Coverage | 2.11 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.09 | |||||
Beneish M-Score | -2.84 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.1 | |||||
3-Year EBITDA Growth Rate | -5.7 | |||||
3-Year EPS without NRI Growth Rate | -42.8 | |||||
3-Year FCF Growth Rate | 7.8 | |||||
3-Year Book Growth Rate | 11.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 16.89 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.43 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | 48.17 | |||||
12-1 Month Momentum % | 103.35 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.58 | |||||
Quick Ratio | 1.84 | |||||
Days Inventory | 107.64 | |||||
Days Sales Outstanding | 50.87 | |||||
Days Payable | 31.62 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 14.6 | |||||
3-Year Average Share Buyback Ratio | -0.3 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 47.31 | |||||
Operating Margin % | 11.48 | |||||
Net Margin % | 4.53 | |||||
FCF Margin % | 13.58 | |||||
ROE % | 6.71 | |||||
ROA % | 2.51 | |||||
ROIC % | 5.68 | |||||
ROC (Joel Greenblatt) % | 28.76 | |||||
ROCE % | 7.09 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 100.76 | |||||
PE Ratio without NRI | 100.76 | |||||
Shiller PE Ratio | 59.8 | |||||
Price-to-Owner-Earnings | 26.45 | |||||
PEG Ratio | 53.03 | |||||
PS Ratio | 2.97 | |||||
PB Ratio | 4.11 | |||||
Price-to-Free-Cash-Flow | 21.82 | |||||
Price-to-Operating-Cash-Flow | 17.88 | |||||
EV-to-EBIT | 31.13 | |||||
EV-to-EBITDA | 19.12 | |||||
EV-to-Revenue | 3.57 | |||||
Price-to-Projected-FCF | 2.26 | |||||
Price-to-DCF (Earnings Based) | 4.19 | |||||
Price-to-DCF (FCF Based) | 1.54 | |||||
Price-to-Median-PS-Value | 0.93 | |||||
Earnings Yield (Greenblatt) % | 3.21 | |||||
FCF Yield % | 4.39 | |||||
Forward Rate of Return (Yacktman) % | 4.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:CMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cantel Medical Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 1,138.391 | ||
EPS (TTM) ($) | 1.256 | ||
Beta | 0 | ||
Volatility % | 46.15 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 0 | ||
12-1 Month Momentum % | 103.35 | ||
52-Week Range ($) | 39.4001 - 89.76 | ||
Shares Outstanding (Mil) | 42.31 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cantel Medical Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cantel Medical Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Cantel Medical Corp Frequently Asked Questions
What is Cantel Medical Corp(CMD)'s stock price today?
When is next earnings date of Cantel Medical Corp(CMD)?
Does Cantel Medical Corp(CMD) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |